Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Apr 4, 2022HiFiBiO Therapeutics Announces Three Presentations at 2022 American Association for Cancer Research (AACR) Annual MeetingJan 10, 2022HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB301001Dec 20, 2021FibroGen Exercises Exclusive License Option for HiFiBiO’s CCR8 ProgramNov 1, 2021HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200301Sep 23, 2021HiFiBiO Therapeutics Contributes to CoVIC-Led Science Publication on SARS-CoV-2 Spike Antibodies Effective Against Variants of Concern< 1 … 5 6 7 8 9 … 17 >
